[Determinants of sensitivity to proteasome inhibitors and strategies to overcome acquired resistance to bortezomib in multiple myeloma]

Rinsho Ketsueki. 2014 Mar;55(3):304-10.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Activating Transcription Factor 3
  • Activating Transcription Factor 4
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / administration & dosage*
  • Boronic Acids / pharmacology
  • Bortezomib
  • Cyclin-Dependent Kinase 5
  • Cytokines
  • DNA-Binding Proteins
  • Dexamethasone / administration & dosage
  • Drug Discovery
  • Drug Resistance, Neoplasm / genetics*
  • Humans
  • Hydroxamic Acids / administration & dosage
  • Indoles / administration & dosage
  • Kruppel-Like Transcription Factors
  • Molecular Targeted Therapy*
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / genetics*
  • Multiple Myeloma / pathology
  • Nicotinamide Phosphoribosyltransferase
  • Oligopeptides / administration & dosage
  • Panobinostat
  • Phosphorylcholine / administration & dosage
  • Phosphorylcholine / analogs & derivatives
  • Proteasome Inhibitors / administration & dosage*
  • Proteasome Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Pyrazines / administration & dosage*
  • Pyrazines / pharmacology
  • Regulatory Factor X Transcription Factors
  • Toyocamycin / administration & dosage
  • Transcription Factors

Substances

  • ATF3 protein, human
  • ATF4 protein, human
  • Activating Transcription Factor 3
  • Boronic Acids
  • Cytokines
  • DNA-Binding Proteins
  • Hydroxamic Acids
  • Indoles
  • KLF9 protein, human
  • Kruppel-Like Transcription Factors
  • Oligopeptides
  • PMAIP1 protein, human
  • Proteasome Inhibitors
  • Proto-Oncogene Proteins c-bcl-2
  • Pyrazines
  • Regulatory Factor X Transcription Factors
  • Transcription Factors
  • Phosphorylcholine
  • Activating Transcription Factor 4
  • perifosine
  • Bortezomib
  • carfilzomib
  • Dexamethasone
  • Panobinostat
  • Nicotinamide Phosphoribosyltransferase
  • nicotinamide phosphoribosyltransferase, human
  • Cyclin-Dependent Kinase 5
  • CDK5 protein, human
  • Toyocamycin